GetTopicDetailResponse(id=1f35183e7da, topicName=venetoclax治療, introduction=venetoclax治療, content=null, image=null, comments=4, allHits=1423, url=https://h5.medsci.cn/topic?id=18377, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=23242, tagList=[TagDto(tagId=23242, tagName=venetoclax治療)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1419617, encodeId=3ba7141961e27, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治療#</a>, objectTitle=NEJM：Venetoclax治療急性髓性白血病（AML），III期臨床取得正面結(jié)果, objectType=article, longId=199491, objectId=6d08199491a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d08199491a0, replyNumber=0, likeNumber=110, createdTime=2020-08-16, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d08199491a0, moduleTitle=NEJM：Venetoclax治療急性髓性白血?。ˋML），III期臨床取得正面結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6d08199491a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1419616, encodeId=33e21419616f3, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治療#</a>, objectTitle=Blood：影響venetoclax治療CLL的療效的因素, objectType=article, longId=165121, objectId=7b7716512115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7716512115, replyNumber=0, likeNumber=96, createdTime=2019-04-29, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7716512115, moduleTitle=Blood：影響venetoclax治療CLL的療效的因素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7b7716512115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1419615, encodeId=63d51419615b6, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治療#</a>, objectTitle=NEJM：venetoclax治療復(fù)發(fā)慢性淋巴細(xì)胞性白血病初見成效, objectType=article, longId=60349, objectId=43666034930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43666034930, replyNumber=0, likeNumber=141, createdTime=2015-12-08, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43666034930, moduleTitle=NEJM：venetoclax治療復(fù)發(fā)慢性淋巴細(xì)胞性白血病初見成效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=43666034930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1419614, encodeId=93441419614a8, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治療#</a>, objectTitle=ASH 2014：venetoclax治療AML的II期研究數(shù)據(jù)公布, objectType=article, longId=44370, objectId=4a7c443e0bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7c443e0bd, replyNumber=0, likeNumber=90, createdTime=2014-12-24, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7c443e0bd, moduleTitle=ASH 2014：venetoclax治療AML的II期研究數(shù)據(jù)公布, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4a7c443e0bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
